Predictive Oncology

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$278
$419
$335
$715
Gross Profit
-38
69
-71
608
EBITDA
-3,025
-4,074
-3,347
-2,994
EBIT
-3,189
-4,236
-3,505
-3,157
Net Income
-3,181
-4,218
-3,475
-3,163
Net Change In Cash
278
419
335
715
Free Cash Flow
-3,224
-3,419
-3,075
-3,108
Cash
5,331
5,197
8,728
11,915
Basic Shares
4,664
4,062
4,062
4,031

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$1,780
$1,505
$1,420
$1,252
Gross Profit
433
1,000
933
805
EBITDA
-13,182
-3,304
-6,679
358
EBIT
-13,921
-4,617
-8,019
-666
Net Income
-13,983
-36,207
-19,657
-37,701
Net Change In Cash
1,780
1,505
1,420
1,252
Cost of Revenue
527
Free Cash Flow
-13,491
-12,846
-13,171
-12,618
Cash
8,728
22,071
28,202
678
Basic Shares
4,014
3,649
2,743
597

Earnings Calls

Quarter EPS
2024-06-30
-$0.68
2024-03-31
-$1.03
2023-12-31
-$0.85
2023-09-30
-$0.78